ProCE Banner Activity

Clinical Trial Results From MVA-BN-RSV Vaccine Candidate for RSV Prevention in Older Adults

Clinical Thought
A new vaccine candidate for prevention of RSV in older adults was added to the EMA’s PRIME scheme. Here’s my summary of the key clinical trial information.

Released: August 18, 2022

Expiration: August 17, 2023

No longer available for credit.

Share

Faculty

Ting Shi

Ting Shi, PhD

Chancellors Fellow
Usher Institute
University of Edinburgh
Edinburgh, United Kingdom

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by an educational grant from

Janssen Pharmaceutica NV

Faculty Disclosure

Primary Author

Ting Shi, PhD

Chancellors Fellow
Usher Institute
University of Edinburgh
Edinburgh, United Kingdom

Ting Shi, PhD, has no relevant financial relationships to disclose.